Abstract |
Recently, common noncoding variants in the TCF7L2 gene were strongly associated with increased risk of type 2 diabetes in samples from Iceland, Denmark, and the U.S. We genotyped 13 single nucleotide polymorphisms (SNPs) across TCF7L2 in 8,310 individuals in family-based and case-control designs from Scandinavia, Poland, and the U.S. We convincingly confirmed the previous association of TCF7L2 SNPs with the risk of type 2 diabetes (rs7903146T odds ratio 1.40 [95% CI 1.30-1.50], P = 6.74 x 10(-20)). In nondiabetic individuals, the risk genotypes were associated with a substantial reduction in the insulinogenic index derived from an oral glucose tolerance test (risk allele homozygotes have half the insulin response to glucose of noncarriers, P = 0.003) but not with increased insulin resistance. These results suggest that TCF7L2 variants may act through insulin secretion to increase the risk of type 2 diabetes.
|
Authors | Richa Saxena, Lauren Gianniny, Noël P Burtt, Valeriya Lyssenko, Candace Giuducci, Marketa Sjögren, Jose C Florez, Peter Almgren, Bo Isomaa, Marju Orho-Melander, Ulf Lindblad, Mark J Daly, Tiinamaija Tuomi, Joel N Hirschhorn, Kristin G Ardlie, Leif C Groop, David Altshuler |
Journal | Diabetes
(Diabetes)
Vol. 55
Issue 10
Pg. 2890-5
(Oct 2006)
ISSN: 0012-1797 [Print] United States |
PMID | 17003358
(Publication Type: Journal Article, Multicenter Study, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Insulin
- TCF Transcription Factors
- TCF7L2 protein, human
- Transcription Factor 7-Like 2 Protein
- Glucose
|
Topics |
- Case-Control Studies
- Diabetes Mellitus, Type 2
(genetics)
- Glucose
(pharmacology)
- Humans
- Insulin
(physiology)
- Insulin Resistance
(genetics)
- Polymorphism, Single Nucleotide
- Risk
- TCF Transcription Factors
(genetics)
- Transcription Factor 7-Like 2 Protein
|